Viveve Medical, Inc. (VIVE)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0002 (-99.50%)
At close: Dec 11, 2025
Viveve Medical Market Cap
Viveve Medical has a market cap or net worth of $11 as of December 12, 2025. Its market cap has decreased by -99.49% in one year.
Market Cap
11.00
Enterprise Value
n/a
Revenue
6.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 27, 2013, Viveve Medical's market cap has decreased from 508.17B to 11.00, a decrease of -100.00%. That is a compound annual growth rate of -86.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 11, 2025 | 11.00 | -99.49% |
| Dec 31, 2024 | 2.15K | - |
| Dec 29, 2023 | 2.15K | -99.95% |
| Dec 30, 2022 | 4.56M | -62.29% |
| Dec 31, 2021 | 12.09M | 18.44% |
| Dec 31, 2020 | 10.21M | 101.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 841.30M |
| Elite Pharmaceuticals | 554.90M |
| Glass House Brands | 491.23M |
| CytoDyn | 415.92M |
| American Oncology Network | 365.47M |
| Northwest Biotherapeutics | 364.04M |
| Silence Therapeutics | 326.39M |
| Nika Pharmaceuticals | 259.91M |